Johnson & Johnson (NYSE:JNJ) shares fell more than 1% intra-day today after the company delivered mixed financial results for the first quarter of 2024, with its adjusted earnings per share (EPS) slightly exceeding expectations, while its revenue slightly missed forecasts. The company announced an adjusted EPS of $2.71, topping the consensus estimate by $0.07, but its quarterly revenue fell just short at $21.38 billion, slightly below the expected $21.4 billion.

Johnson & Johnson also adjusted its full-year 2024 guidance, raising the midpoint for both operational sales and adjusted operational EPS, indicating optimism about its growth trajectory. The company now anticipates sales between $88 billion and $88.4 billion, with adjusted EPS forecasted to range from $10.57 to $10.72.

Additionally, Johnson & Johnson declared a quarterly dividend of $1.24 per share, a 4.2% increase from the previous $1.19, resulting in an annualized yield of 3.4%.